Watson-Marlow 620 Pumps Doubles Polpharma Productivity

Contributed by: PumpScout Staff

Polpharma, the leading manufacturer of pharmaceuticals in Poland, is using peristaltic pump technology from Watson-Marlow Fluid Technology Group (WMFTG), the world leader in niche peristaltic pumps and associated fluid path technologies. Productivity has been boosted at Polpharma’s manufacturing plant in Starogard Gdański. After five years of using existing 600 series technology, another 620 series process pump has been used recently to transfer liquids between tanks, doubling the productivity of the production line.

"The decision to purchase another Watson-Marlow pump was dictated by a rational plan to increase the productivity of the plant,” explains Polpharma engineer, Damian Szymanowicz. “Put simply, we were so pleased with the performance of our existing 620U process pump, that when we were looking to install another, there was no question of looking beyond another pump from Watson-Marlow.”

The 620 series process pump is also used with Pumpsil platinum-cured silicone tubing, which allows the Starogard Gdański plant to avoid contamination between batches. The pump is specifically engineered for post-irradiation dispensing stability and is post-cured for the lowest amount of extractables.

“The pumps work seamlessly with the rest of the instrumentation located at the plant,” confirms Mr. Szymanowicz. “The reliability and efficiency of the 620 series process pump has proven itself over five years of operation. We have seen for ourselves that the high-quality pump reduces the cost of upgrades and guarantees a long working life. The pumps have certainly improved our performance and allowed for further development of the company’s manufacturing ability."

Because these pumps are so dependable, they are an especially good choice for Polpharma, which is a generic drug manufacturer that is among the top 20 in the world.

"Pharmaceutical and biotechnology industries require sterility and precision in order to ensure the highest quality of the final product,” says Rafal Łydziński, a representative of Watson-Marlow Poland. “The separation of liquids and precise flow control are crucial. Many years of cooperation with drug manufacturers has been for us an expression of mutual trust and effective understanding of customer needs.”

Source: Watson-Marlow

FirewalledRequest[ org.apache.catalina.core.ApplicationHttpRequest@5e73b793]